Search

Your search keyword '"Matin, Khalid"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Matin, Khalid" Remove constraint Author: "Matin, Khalid"
43 results on '"Matin, Khalid"'

Search Results

1. Patient care in complex Sociotechnological ecosystems and learning health systems

2. Effectiveness of a Cardiovascular Health Electronic Health Record Application for Cancer Survivors in Community Oncology Practice: Results From WF-1804CD

8. SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

9. An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials

10. Prostate Cancer

11. Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement

12. Assessing feasibility and utility of an implicit bias training program for addressing disparities in cancer clinical trial participation.

14. A phase 1 study of neoadjuvant chemotherapy followed by concurrent chemoradiation with gemcitabine, sorafenib, and vorinostat in pancreatic cancer.

17. Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients With Advanced Cancer

20. In the case of prostate cancer patients, are there advantages in cancer nurse-led follow-up?

30. Understanding the non-curative potential of palliative chemotherapy: Do patients hear what they want to hear?

31. Identifying How Patient Portals Impact Communication in Oncology.

32. OpenNotes in oncology: oncologists' perceptions and a baseline of the content and style of their clinician notes.

37. A phase 2 basket trial of ulixertinib (BVD-523) in combination with hydroxychloroquine in patients with advanced gastrointestinal malignancies harboring MAPK pathway mutations (BVD-523-HCQ).

41. Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer

42. A Phase I/II Study of Trimetrexate and Capecitabine in Patients With Advanced Refractory Colorectal Cancer

43. SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.

Catalog

Books, media, physical & digital resources